Delta Financial Group, Inc. Esperion Therapeutics, Inc. Transaction History
Delta Financial Group, Inc.
- $438 Million
- Q1 2025
A detailed history of Delta Financial Group, Inc. transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Delta Financial Group, Inc. holds 23,150 shares of ESPR stock, worth $67,135. This represents 0.01% of its overall portfolio holdings.
Number of Shares
23,150
Previous 23,350
0.86%
Holding current value
$67,135
Previous $51,000
21.57%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding ESPR
# of Institutions
213Shares Held
114MCall Options Held
643KPut Options Held
769K-
Black Rock Inc. New York, NY14MShares$40.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.1MShares$35.1 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY9.75MShares$28.3 Million0.51% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT7.06MShares$20.5 Million0.1% of portfolio
-
Pender Fund Capital Management Ltd. Vancouver, A16.68MShares$19.4 Million7.68% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $193M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...